Bristol-Myers Squibb's deucravacitinib – one of the main pipeline assets in its $74 billion takeover of Celgene in 2019 – has been approved in its first market as a treatment for moderate-to-severe ...

Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

The phase 3 comeback story Bristol Myers Squibb investors were eagerly anticipating is not to be—at least not this year. The highly anticipated Adept-2 study will not read out by year-end as ...

A recent McKinsey mobility survey shows that automobile owners are prioritizing battery range, charging speeds, and reliability when considering an electric vehicle (EV). Automakers are responding to ...

In this workshop, we’ll explore the process of relighting a 3D environment in Unreal Engine, taking inspiration from Luminism ...

With the precision of monoclonal antibodies and the potency of small-molecular payloads, antibody-drug conjugates (ADC) are promising cancer therapeutics. As of this year, there are 19 ADC drugs ...

When single-molecule super-resolution microscopes were first commercialized some 15 years ago, they made headlines for their ability to resolve individual molecules and structures at the nanometer ...

Abstract: Battery monitoring is vital for most electric vehicles (EVs), because the safety, operation, and even the life of the passenger depends on the battery system. This attribute is exactly the ...

Abstract: I welcome you to the fourth issue of the IEEE Communications Surveys and Tutorials in 2021. This issue includes 23 papers covering different aspects of communication networks. In particular, ...

Burning mouth syndrome is linked to nerve pain and needs medical treatment. Most people with burning mouth syndrome will feel better within weeks to months. Women are more likely to develop burning ...

† Bristol-Myers Squibb Research and Development, P.O. Box 5100, 5 Research Parkway, Wallingford, Connecticut 06492, United States ‡ Department of Discovery Chemistry, Biocon Bristol-Myers Squibb ...